Concord Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

1,016.94

853.17

712.93

616.40

512.33

Operating profit

431.56

343.29

273.28

327.11

204.07

Interest

2.55

4.51

5.48

0.52

0.70

Gross profit

462.79

374.09

291.21

340.69

234.74

EPS (Rs)

29.13

22.76

18.78

24.74

17.77

Other income

33.78

35.31

23.42

14.10

31.37

Stock adjustment

-12.08

-15.63

-23.98

-39.05

-4.85

Raw material

184.54

167.07

157.26

131.17

124.01

Power and fuel

-

-

-

-

-

Employee expenses

123.05

110.28

95.69

69.47

62.24

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

289.88

248.16

210.69

127.70

126.86

Provisions made

-

-

-

-

-

Depreciation

53.59

54.03

50.05

27.52

21.25

Taxation

104.46

81.93

62.59

77.83

44.53

Net profit / loss

304.73

238.13

178.57

235.33

168.96

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.46

10.46

9.51

9.51

9.51

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

42.44

40.24

38.33

53.07

39.83

GPM (%)

44.04

42.10

39.55

54.03

43.17

NPM (%)

29.00

26.80

24.25

37.32

31.08